<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diagnosis of chronic obstructive pulmonary disease: PFTs and chest radiograph</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diagnosis of chronic obstructive pulmonary disease: PFTs and chest radiograph</h1>
<div class="graphic"><div class="figure"><div class="ttl">Diagnosis of chronic obstructive pulmonary disease: PFTs and chest radiograph</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1_single">Spirometry</td> </tr> <tr> <td class="indent1">Spirometry is the essential test to confirm the diagnosis and establish the staging of COPD. If values are abnormal, a post-bronchodilator test may be indicated. Airflow limitation that is irreversible or only partially reversible with bronchodilator is suggestive of COPD rather than asthma. A postbronchodilator ratio of FEV<sub>1</sub>/FVC &lt;0.7 or &lt;LLN of FEV<sub>1</sub>/FVC is used to establish the presence of airflow limitation.</td> </tr> <tr> <td class="indent1">In the presence of a low FEV<sub>1</sub>/FVC, the percent of predicted FEV<sub>1</sub> is used to determine the severity of airflow limitation. <ul class="decimal_heading"> <li>GOLD 1: Mild (FEV<sub>1</sub> ≥80% predicted) </li> <li>GOLD 2: Moderate (50% predicted ≤FEV<sub>1</sub> &lt;80% predicted) </li> <li>GOLD 3: Severe (30% predicted ≤FEV<sub>1</sub> &lt;50% predicted) </li> <li>GOLD 4: Very severe (FEV<sub>1</sub> &lt;30% predicted) </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Lung volumes</td> </tr> <tr> <td class="indent1">Body plethysmography to assess lung volumes is not necessary except in patients with a low FVC on spirometry (&lt;80% predicted) or when concomitant interstitial lung disease is suspected.</td> </tr> <tr> <td class="subtitle1_single">Diffusing capacity for carbon monoxide</td> </tr> <tr> <td class="indent1">Measurement of DLCO can help establish the presence of emphysema, but is not necessary for the routine diagnosis of COPD.</td> </tr> <tr> <td class="subtitle1_single">Chest radiography</td> </tr> <tr> <td class="indent1">Evidence of hyperinflation (eg, enlarged lungs, flattened diaphragm, increased AP diameter) and loss of parenchyma (eg, decreased lung markings, large bullae) are typically only present and diagnostic in severe emphysema. Radiography is frequently obtained to exclude other lung disease.</td> </tr> <tr> <td class="subtitle1_single">Arterial blood gases (ABGs)</td> </tr> <tr> <td class="indent1">Mild and moderate airflow obstruction – ABG usually not needed.</td> </tr> <tr> <td class="indent1">Moderately severe airflow obstruction – ABG is optional, but oximetry should be done. ABGs are obtained if oxygen saturation is &lt;92%.</td> </tr> <tr> <td class="indent1">Severe and very severe airflow obstruction – ABGs are essential to assess for hypercapnia.</td> </tr> </tbody></table></div><div class="graphic_footnotes">PFTs: pulmonary function tests;
COPD: chronic obstructive pulmonary disease;
FEV<sub>1</sub>: forced expiratory volume in 1 second;
FVC: forced vital capacity;
LLN: lower limit of normal;
GOLD: Global Initiative for Chronic Obstructive Lung Disease;
DLCO: diffusing capacity for carbon monoxide;
ABG: arterial blood gas.</div><div id="graphicVersion">Graphic 61983 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
